PubMed Health⌕ Search

PubMed · 7237300

Evolution of ileostomy surgery.

Abstract

Ileostomy in association with proctocolectomy in one or two stages is the accepted treatment for ulcerative colitis. There are many difficulties in managing the permanent ileostomy in spite of improvements in design and construction, in availability of stomal appliances and in better skin protection and adhesive materials. The collection and storage of excrement in a bag outside the body imposes severe difficulties. To eliminate these problems an alternative ileostomy method, the continent ileostomy, was devised and the clinical results achieved in 314 patients are reported. There was a 2.2% overall operative mortality but no operative deaths in the last consecutive series of 152 patients. The nonfatal complication rate has decreased from 24% to 7% and revision because of a malfunctioning outlet valve has decreased from 54% to 6%. At follow-up 94% of the patients were continent. Except for a slightly increased loss of bile salts and a potential risk of decreased vitamin B12 absorption no harmful effects of the reservoir procedure have been found after observation times up to 12 years.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

N G Kock. 1981. Evolution of ileostomy surgery.. https://pubmed.ncbi.nlm.nih.gov/7237300/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Hypothesis about mechanisms through which nicotine might exert its effect on the interdependence of inflammation and gut barrier function in ulcerative colitis.

Ulcerative colitis (UC) is characterized by impairment of the epithelial barrier and the formation of ulcer-type lesions, which result in local leaks and generalized alterations of mucosal tight junctions. Ultimately, this results in increased basal permeability. Although disruption of the epithelial barrier in the gut is a hallmark of inflammatory bowel disease and intestinal infections, it remains unclear whether barrier breakdown is an initiating event of UC or rather a consequence of an underlying inflammation, evidenced by increased production of proinflammatory cytokines. UC is less common in smokers, suggesting that the nicotine in cigarettes may ameliorate disease severity. The mechanism behind this therapeutic effect is still not fully understood, and indeed it remains unclear if nicotine is the true protective agent in cigarettes. Nicotine is metabolized in the body into a variety of metabolites and can also be degraded to form various breakdown products. It is possible these metabolites or degradation products may be the true protective or curative agents. A greater understanding of the pharmacodynamics and kinetics of nicotine in relation to the immune system and enhanced knowledge of gut permeability defects in UC are required to establish the exact protective nature of nicotine and its metabolites in UC. This review suggests possible hypotheses for the protective mechanism of nicotine in UC, highlighting the relationship between gut permeability and inflammation, and indicates where in the pathogenesis of the disease nicotine may mediate its effect.

Colitis, Ulcerative↗